New Delhi: Emcure Pharmaceuticals has announced the signing of a distribution agreement with Roche for select products in the nephrology and transplant medicine portfolio, marking a significant step ...

LOS ANGELES--(BUSINESS WIRE)--Children’s Hospital Los Angeles (CHLA) is expanding its safety protocol for patients receiving Elevidys®, the FDA-approved gene therapy for Duchenne muscular dystrophy ...

Amneal Pharma ((AMRX)), Sandoz Group Ltd ((SDZXF)), Alkem Laboratories Ltd. ((IN:ALKEM)), Concord Biotech Ltd. ((IN:CONCORDBIO)) announced an update on their ongoing clinical study. Take advantage of ...

This immunosuppressant medication is FDA-approved to prevent organ transplant rejection. It is used off-label to treat several rheumatic diseases, including lupus, rheumatoid arthritis (RA), ...

This immunosuppressant medication is FDA-approved to prevent organ transplant rejection. It is used off-label to treat several rheumatic diseases, including lupus nephritis and systemic sclerosis ...

CellCept can cause certain side effects, some of which are more common than others. These side effects may be temporary, lasting a few days to weeks. However, if the side effects last longer than that ...

Myasthenia gravis (MG) has been treatable for nearly 100 years. In 1934, the Scottish doctor Mary Broadfoot Walker, MD, discovered that the drug physostigmine improved muscle function in people with ...

CellCept (mycophenolate mofetil) is a prescription drug that helps prevent organ rejection after certain organ transplants. CellCept can interact with other medications and some supplements. For ...

Indian generic drugmaker Strides Pharma Science (BSE: 532531) announced that its stepdown wholly-owned subsidiary, Strides Pharma Global Pte Limited, Singapore, has received approval for mycophenolate ...

CellCept (mycophenolate mofetil) is a prescription drug used to prevent organ rejection after certain organ transplants. CellCept’s cost may depend on factors such as your dosage, whether you have ...

CellCept (mycophenolate mofetil) is a brand-name drug that’s prescribed to help prevent organ rejection after a transplant in adults and some children. CellCept comes in several forms. The dosage can ...

A new study finds therapies used to treat lupus (mycophenolate mofetil (CellCept®), tacrolimus (Protopic®), and belimumab (Benlysta®) significantly reduce a person’s response to the COVID-19 vaccine.